COBRA: TOL+ INTERFERON-alpha COMBINED WITH VEMURAFENIB (BRAF-mutation positive patients) OR TOL + INTERFERON- alpha (BRAF-mutation negative patients) FOR PATIENTS WITH ADVANCED MELANOMA AS 1st CHEMOTHERAPY-BASED TREATMENT
Latest Information Update: 06 Dec 2022
At a glance
- Drugs Vemurafenib (Primary) ; Antineoplastics; Interferon alpha
- Indications Malignant melanoma
- Focus Therapeutic Use
- Acronyms COBRA
- 20 Aug 2013 New trial record